(Q37459918)

20 August 2017

1 reference

title

The long-term risks and benefits of hormone replacement therapy (English)

1 reference

20 August 2017

Hillard TC

1

1 reference

20 August 2017

Whitcroft S

series ordinal

2

1 reference

20 August 2017

Ellerington MC

series ordinal

3

1 reference

20 August 2017

Whitehead MI

series ordinal

4

1 reference

20 August 2017

language of work or name

1 reference

1 August 1991

1 reference

Journal of Clinical Pharmacy and Therapeutics

20 August 2017

1 reference

20 August 2017

16

1 reference

20 August 2017

4

1 reference

20 August 2017

231-245

1 reference

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

20 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Menopause and coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Menopausal oestrogen therapy and protection from death from ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

A prospective study of postmenopausal estrogen therapy and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Estrogen use and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Consensus conference: Progestagen use in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Menopausal oestrogens and breast cancer risk: an expanded case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Ovarian cancer incidence and mortality in Denmark, 1943-1982.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Insudative hyalin cap lesions of diabetic glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Estrogen use in postmenopausal women--costs, risks, and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1991.TB00310.X

10.1111/J.1365-2710.1991.TB00310.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference